Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples-Reference-Cited by-同舟云学术

Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples

Published:2023-12 Issue: Volume:127 Page:110830
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Milos Tina,Rojo David,Nedic Erjavec Gordana,Konjevod Marcela,Tudor Lucija,Vuic Barbara,Svob Strac Dubravka,Uzun Suzana,Mimica Ninoslav,Kozumplik Oliver,Barbas Coral,Zarkovic Neven,Pivac Nela,Nikolac Perkovic Matea

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference95 articles.

1. Lipid profiling of Alzheimer’s disease brain highlights enrichment in glycerol(phospho)lipid, and sphingolipid metabolism;Akyol;Cells,2021

2. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Albert;Alzheimers Dement.,2011

3. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer’s disease (AD) patients;Aldred;Arch. Gerontol. Geriatr.,2010

4. Diagnostic and Statistical Manual of Mental Disorders;APA,2013

5. Mini-mental state examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI);Arevalo-Rodriguez;Cochrane Database Syst. Rev.,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiota in combination with blood metabolites reveals characteristics of the disease cluster of coronary artery disease and cognitive impairment: a Mendelian randomization study;Frontiers in Immunology;2024-01-15